Cision PR Newswire

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....

ENERGIZER LAUNCHES THE WORLD’S FIRST 3-IN-1 CHILD SHIELD™ COIN-CELL LITHIUM RANGE IN MALAYSIA

The new Energizer 3-in-1 Child Shield™ features the exclusive new colour alert technology, child-resistant packaging, and a non-toxic bitter coating to...

Fosun Wealth Holdings Strengthens Fintech Strategy as Finloop Becomes a Strategic Enterprise of OASES

HONG KONG, April 9, 2025 /PRNewswire/ -- Finloop Finance Technology Holding Limited ("Finloop"), an AI-driven one-stop institutional wealth management platform incubated by Fosun Wealth...

BaseCare Medical (2170.HK) Unveils First Smart Home Sperm Analyzer, Pioneering “B+C” Full-Scenario Intelligent Expansion

SUZHOU, China, April 9, 2025 /PRNewswire/ -- BaseCare Medical, a trailblazer in reproductive health and China's first publicly traded company in the assisted reproductive...

Sandbrook Capital and PSP Investments Announce Sale of Offshore Wind Pioneer Havfram to DEME

LONDON, MONTREAL, and OSLO, Norway, April 9, 2025 /PRNewswire/ -- Sandbrook Capital, a private investment firm focused on building leading climate infrastructure companies, and...